InterVene Completes First 30 Cases Using Recana Thrombectomy Catheter

Got story updates? Submit your updates here. ›

InterVene, a medical device company, has completed the first 30 cases using its Recana Thrombectomy Catheter System, a new device designed to remove blood clots. The company is now planning a broader commercial launch of the product after the successful initial procedures.

Why it matters

The Recana Thrombectomy Catheter System represents a new treatment option for patients suffering from blood clots, which can be a serious and potentially life-threatening condition. The successful initial cases demonstrate the device's effectiveness and pave the way for wider adoption, potentially improving outcomes for many patients.

The details

The Recana Thrombectomy Catheter System is a minimally invasive device used to remove blood clots from veins and arteries. It works by using a specialized catheter to break up and suction out the clot, restoring blood flow. InterVene reported that the first 30 cases using the device were completed without any major complications, indicating its safety and efficacy.

• The first 30 cases using the Recana Thrombectomy Catheter System were completed in April 2026.

What’s next

InterVene plans to launch the Recana Thrombectomy Catheter System more broadly in the coming months, making the device available to more healthcare providers and patients.